190PDResearch-based PAM50 predicts risk of relapse in residual disease after anti-HER2 therapies

Title
190PDResearch-based PAM50 predicts risk of relapse in residual disease after anti-HER2 therapies
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 29, Issue suppl_8, Pages -
Publisher
Oxford University Press (OUP)
Online
2018-10-25
DOI
10.1093/annonc/mdy270.187

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More